---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-233473"
form_type: "8-K"
ticker: "ZBH"
cik: "0001136869"
company_name: "ZIMMER BIOMET HOLDINGS, INC."
filed_at: "2025-10-07T23:59:59+00:00"
generated_at: "2026-05-17T04:24:16.993796+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Zimmer Biomet completes acquisition of Monogram Technologies for $4.04/sh plus CVRs up to $12.37

## Summary
- Each Monogram common share converted to $4.04 cash and non-tradeable CVRs worth up to $12.37 upon milestone achievement.
- Acquisition adds AI-driven semi- and fully autonomous robotics for TKA; FDA 510(k) clearance March 2025, commercialization expected early 2027.
- Zimmer Biomet now offers broadest orthopedic robotics portfolio including ROSA platform; nearing 2,000 installations worldwide.
- Monogram shares ceased trading on NASDAQ and will be delisted as of October 7, 2025.

## SEC filing metadata
- accession: 0001193125-25-233473
- form_type: 8-K
- ticker: ZBH
- cik: 0001136869
- company_name: ZIMMER BIOMET HOLDINGS, INC.
- filed_at: 2025-10-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1136869/000119312525233473/0001193125-25-233473-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1136869/000119312525233473/d938765d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-233473
- JSON: https://secwatch.observer/filing/0001193125-25-233473.json
- Plain text: https://secwatch.observer/filing/0001193125-25-233473.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.